Registration Details
This event is part of a series of Technology Partn3Ring webinars focusing on new approach methodologies (NAMs), which are replacement technologies for use in assessing chemical or drug toxicity.
The first NAMs webinar will include presentations from researchers working across invertebrate models as partial replacements for the use of mammals, human-relevant microphysiological systems, drug efficacy and drug/consumer product toxicity testing.
Learn more about the NAMs Technology Partn3Ring webinar series, including other upcoming sessions and previous recordings.
Speakers and topics
Early drug screening with C. elegans: A 3Rs-aligned approach
Sara Leighton (Magnitude Biosciences Limited)
- High-throughput C. elegans platform, delivering scalable and predictive insights on drug efficacy, safety and mechanism of action.
- Seeking collaborators to further qualify screening platform and provide access to comparator datasets.
From model to method: Validating C. elegans-based DART assay towards regulatory use
Eva Martini (Nagi Bioscience)
- Providing human relevant whole organism toxicity data that can replace early mammalian screens.
- Seeking collaborators for new toxicology use cases, cross‑species comparison, and standardisation towards regulatory readiness.
Title TBC
Vitaliy Khutoryanskiy (University of Reading)
- Developing invertebrate assays that can replace early-stage mammalian studies in toxicity, irritation, infection and formulation screening.
- Seeking collaborators interested in co-developing and qualifying the invertebrate-based assays for broader application and increased translational relevance.
Title TBC
Margaret Magdesian (Ananda Devices)
- Developing human iPSC‑based neuro and neuromuscular assays towards replacing animal use in neurotoxicity assays.
- Seeking partners to benchmark and expand assay applications, including exploring incorporation into regulatory workflows.
About Technology Partn3Ring webinars
The NC3Rs Technology Partn3Ring webinars showcase technologies with 3Rs potential to the wider scientific community to identify new partners for further development and use. Open to researchers, clinicians, pharmaceutical and industry professionals, each webinar features short pitches outlining 3Rs research, tools and technologies. Attendees can ask questions and connect with the speakers to access unique collaboration opportunities.